WHO ICTRP trial
Clinical study of flupentixol and melitroxine in the treatment of refractory…
ChiCTR2000035304 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000035304 |
|---|---|
| Public title | Clinical study of flupentixol and melitroxine in the treatment of refractory cough |
| Scientific title | Clinical study of flupentixol and melitroxine in the treatment of refractory cough |
| Primary sponsor | Shanghai Tongji Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Refractory cough |
| Interventions | experimental group:Flupenthixol and Meritroxine ;control group:Placebo |
| Registration date | Aug 7, 2020 |
| Target size | experimental group:51;control group:51 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: